Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN119,08119,18-0,10
Msft0,11
Nokia6,5566,866-0,57
IBM-2,13
Mercedes-Benz Group AG54,2554,12-0,97
PFE-0,89
10.03.2026 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 09.03.2026 21:15:00
Cigna Rg (NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
269,66 -0,73 -1,97 302 307 501
After-hours10.03.2026 1:04:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
269,66 - - -0,73 -1,97
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 10.03.2026
Popis společnosti
Obecné informace
Název společnostiCigna Group
TickerCI
Kmenové akcie:Ordinary Shares
RICCI
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.12.2025 67 700
Akcie v oběhu k 30.01.2026 263 528 277
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice900 Cottage Grove Road
MěstoBLOOMFIELD
PSČ06002
ZeměUnited States
Kontatní osobaRalph Giacobbe
Funkce kontaktní osobyInvestor Relations
Telefon13 026 587 581
Fax13026555049
Kontatní telefon18 607 877 968

Business Summary: The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Cigna Group revenues increased 11% to $274.9B. Net income increased 73% to $5.96B. Revenues reflect Evernorth segment increase of 16% to $234.95B. Net income benefited from Selling, Genernal and Administrative Exp decrease of 7% to $13.56B (expense), Interest Exp-Net of Capitalized Interest decrease of 2% to $1.41B (expense). Dividend per share increased from $5.71 to $6.09.



  • Poslední aktualizace: 10.03.2026
Management společnosti
FunkceFunkceJménoJménoVěkVe funkci odVe firmě odVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerChairman of the Board, Chief Executive OfficerDavid Cordani31.03.2025 0:00:0001.01.2008 0:00:005931.03.2025 0:00:0001.01.2008 0:00:00
President, Chief Operating OfficerPresident, Chief Operating OfficerBrian Evanko31.03.2025 0:00:00 4931.03.2025 0:00:00 
Chief Financial Officer, Executive Vice PresidentChief Financial Officer, Executive Vice PresidentAnn Dennison31.03.2025 0:00:0031.03.2025 0:00:005431.03.2025 0:00:0031.03.2025 0:00:00
Executive Vice President, Chief Administrative Officer, General CounselExecutive Vice President, Chief Administrative Officer, General CounselNicole Jones  54